Hasford score: online calculator

Sokal, Hasford, and EUTOS scores were developed at different times in the treatment of chronic myeloid leukemia (CML). Hasford score is a prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Interferon alfa is a conservative and widely used alternative to bone marrow transplantation in treatment of patients with early chronic myeloid leukemia before tyrosine kinase inhibitors implementation in clinical practice. 

Age:

Spleen size
Maximum distance palpable below costal margin:


Cm
Inches

Platelet count:

10⁹/L
10³/µL

Peripheral blood blasts (% of leukocytes):

Peripheral blood eosinophils (% of leukocytes):

Peripheral blood basophils (% of leukocytes):



Patient’s Hasford score Hasford score range Hasford risk group
0 0 0

0.666 when age ≥50 years + (0.042 x spleen) + 1.0956 when platelet count > 1500 x109/l + (0.0584 x blasts cells) + 0.20399 when basophils  > 3% + (0.0413 x eosinophils)x100

  • Age in years
  • Spleen is in cm below the costal margin
  • Blast cells, eosinophils and basophils are in percent of peripheral blood differential.

Hasford score

  • ≤ 780 – Low risk
  • 781-1480 – Intermediate risk
  • ≥1480 – High risk 

A source:
Hasford J, Pfirrmann M, Hehlmann R, Allan NC, Baccarani M, Kluin-Nelemans JC et al. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. J Natl Cancer Inst. 1998; 90: 850-8.



Read also:


Register on our website right now to have access to more learning materials!

Multiple Myeloma Diagnostic Criteria – Online Calculator

Loading...

≥1 of the following (A or B)

≥1 myeloma defining event (C1 or C2)


* Required
For Multiple Myeloma Diagnostic Criteria assessment necessary to provide selection of the…
Read More

SAVED VTE Score

SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. [ezfc…

Read More

IMPEDE VTE Score

IMPEDE score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. [ezfc…

Read More
Share:

Related Articles

Register and get a gift!

User registration







  • Use only Latin letters and numbers.













  • Strength indicator

    Password at least 12 characters, uppercase and lowercase letters, numbers and symbols like! "? $ ^ &